FI912963A0 - Hjaernverksamheten oekande pyrimidinylderivat. - Google Patents

Hjaernverksamheten oekande pyrimidinylderivat.

Info

Publication number
FI912963A0
FI912963A0 FI912963A FI912963A FI912963A0 FI 912963 A0 FI912963 A0 FI 912963A0 FI 912963 A FI912963 A FI 912963A FI 912963 A FI912963 A FI 912963A FI 912963 A0 FI912963 A0 FI 912963A0
Authority
FI
Finland
Prior art keywords
oekande
hjaernverksamheten
pyrimidine derivatives
pyrimidine
derivatives
Prior art date
Application number
FI912963A
Other languages
English (en)
Other versions
FI912963A (fi
Inventor
Ronald J Mattson
Robert Mayol
Michael E Brady
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of FI912963A0 publication Critical patent/FI912963A0/fi
Publication of FI912963A publication Critical patent/FI912963A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
FI912963A 1990-06-27 1991-06-18 Hjaernverksamheten oekande pyrimidinylderivat. FI912963A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/544,570 US5098904A (en) 1990-06-27 1990-06-27 Cerebral function enhancing pyrimidinyl derivatives

Publications (2)

Publication Number Publication Date
FI912963A0 true FI912963A0 (fi) 1991-06-18
FI912963A FI912963A (fi) 1991-12-28

Family

ID=24172727

Family Applications (1)

Application Number Title Priority Date Filing Date
FI912963A FI912963A (fi) 1990-06-27 1991-06-18 Hjaernverksamheten oekande pyrimidinylderivat.

Country Status (15)

Country Link
US (1) US5098904A (fi)
EP (1) EP0463596A1 (fi)
JP (1) JPH04230279A (fi)
KR (1) KR920000748A (fi)
CN (1) CN1057651A (fi)
AU (1) AU628735B2 (fi)
CA (1) CA2041257A1 (fi)
FI (1) FI912963A (fi)
HU (1) HUT58318A (fi)
IE (1) IE912210A1 (fi)
IL (1) IL98541A0 (fi)
NO (1) NO912448L (fi)
NZ (1) NZ238572A (fi)
PT (1) PT98083A (fi)
ZA (1) ZA914626B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993022309A1 (en) * 1992-04-23 1993-11-11 Merrell Dow Pharmaceuticals Inc. 4-imidomethyl-1-[2'phenyl-2'oxoethyl-] piperidines as serotonin 5ht2-antagonists, their preparation and use in therapy
EP0662962A1 (en) * 1992-09-28 1995-07-19 Pfizer Inc. Substituted pyrimidines for control of diabetic complications
US5338738A (en) * 1993-04-19 1994-08-16 Bristol-Myers Squibb Company Cerebral function enhancers: acyclic amide derivatives of pyrimidinylpiperidines
US5401744A (en) * 1993-10-04 1995-03-28 Bristol-Myers Squibb Company Useful hemi-hydrate form of a cerebral function enhancing agent
US5601091A (en) * 1995-08-01 1997-02-11 Sonamed Corporation Audiometric apparatus and association screening method
JP4617449B2 (ja) 2002-07-11 2011-01-26 ヴィキュロン ファーマシューティカルズ インコーポレイテッド 抗菌活性を有するｎ−ヒドロキシアミド誘導体
US11619880B2 (en) * 2019-05-17 2023-04-04 The Regents Of The University Of Colorado Holographic photopolymer compositions and composites

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3398151A (en) * 1966-02-01 1968-08-20 Mead Johnson & Co Azaspirodecanediones and azaspiroundecanediones
US3558777A (en) * 1968-06-21 1971-01-26 Mead Johnson & Co Pharmacologic processes and compositions containing azaspirodecanediones and azaspiroundecanediones
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
DK251079A (da) * 1978-06-20 1979-12-21 Synthelabo Fremgangsmaade til fremstilling af phenylpiperazinderivater
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4423049A (en) * 1981-12-28 1983-12-27 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines
US4361565A (en) * 1981-12-28 1982-11-30 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines
US4524206A (en) * 1983-09-12 1985-06-18 Mead Johnson & Company 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives
US4668687A (en) * 1984-07-23 1987-05-26 Bristol-Myers Company Psychogeriatric 1-(2-pyrimidinyl)piperazinyl derivatives of 1-pyrrolidin-2-ones
NZ216720A (en) * 1985-07-08 1990-09-26 Bristol Myers Co Diazinylpiperidine derivatives and pharmaceutical compositions
US4826843A (en) * 1985-07-08 1989-05-02 Bristol-Myers Cerebral function enhancing diazinylpiperidine derivatives
US4963678A (en) * 1989-10-27 1990-10-16 Bristol-Myers Squibb Co. Process for large-scale production of BMY 21502

Also Published As

Publication number Publication date
CA2041257A1 (en) 1992-01-28
EP0463596A1 (en) 1992-01-02
HU912123D0 (en) 1991-12-30
AU628735B2 (en) 1992-09-17
US5098904A (en) 1992-03-24
NO912448D0 (no) 1991-06-24
KR920000748A (ko) 1992-01-29
NZ238572A (en) 1993-07-27
IL98541A0 (en) 1992-07-15
FI912963A (fi) 1991-12-28
AU7627591A (en) 1992-01-02
ZA914626B (en) 1993-02-24
HUT58318A (en) 1992-02-28
NO912448L (no) 1991-12-30
IE912210A1 (en) 1992-01-01
JPH04230279A (ja) 1992-08-19
PT98083A (pt) 1992-04-30
CN1057651A (zh) 1992-01-08

Similar Documents

Publication Publication Date Title
DE59108494D1 (de) 1-H-3-Aryl-pyrrolidin-2,4-dion-Derivate
DE69119329T2 (de) Actinonin-Derivate
DE3788385T2 (de) Pyrimidin-Derivate.
DE69110254T2 (de) Hydroxychinolonderivate.
MC1846A1 (fr) Derives de pyrimidine
DE69125099T2 (de) Indolderivate
ATE144765T1 (de) Hiv-hemmende benzenacetamidderivate
ATE171449T1 (de) Oxadolderivate
LV11176A (lv) Uracila atvasinajumi
DE69110093T2 (de) Pyrimidinderivate.
TR27090A (tr) Tetrahidropirimidin türevleri.
TR26336A (tr) SüBSTITüE EDILMIS PIRAZOLIN TüREVLERI
MX9205003A (es) Derivados novedosos de benzopirano.
ITMI912655A1 (it) Combinazione di estrusore-calandra.
MC1934A1 (fr) Derives de pyrimidine
MC1844A1 (fr) Derives de pyrimidine
DE3884347D1 (de) Pyrimidinderivate.
MC1845A1 (fr) Derives de pyrimidine
FI912963A (fi) Hjaernverksamheten oekande pyrimidinylderivat.
MX9204370A (es) Derivados de pirazol.
DE59106761D1 (de) N-Acylpyrrolidin-Derivate.
MX9205973A (es) Derivados de benzo-isoquinolinas.
MX9201931A (es) Nuevos derivados de tiazol.
DE69004844T2 (de) Pyrimidin-Derivate.
FI913285A0 (fi) Svavelsubstituerade mevinsyraderivat.